DK514285A - 5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse - Google Patents

5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse Download PDF

Info

Publication number
DK514285A
DK514285A DK514285A DK514285A DK514285A DK 514285 A DK514285 A DK 514285A DK 514285 A DK514285 A DK 514285A DK 514285 A DK514285 A DK 514285A DK 514285 A DK514285 A DK 514285A
Authority
DK
Denmark
Prior art keywords
diazoh
cyanopyridine
hydroxide
procedures
preparation
Prior art date
Application number
DK514285A
Other languages
English (en)
Other versions
DK159847B (da
DK159847C (da
DK514285D0 (da
Inventor
David C Baker
Original Assignee
Univ Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alabama filed Critical Univ Alabama
Publication of DK514285D0 publication Critical patent/DK514285D0/da
Publication of DK514285A publication Critical patent/DK514285A/da
Publication of DK159847B publication Critical patent/DK159847B/da
Application granted granted Critical
Publication of DK159847C publication Critical patent/DK159847C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK514285A 1984-11-13 1985-11-07 Salte af 5-cyanopyridin-2-diazohydroxid DK159847C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/670,203 US4636564A (en) 1984-11-13 1984-11-13 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
US67020384 1984-11-13

Publications (4)

Publication Number Publication Date
DK514285D0 DK514285D0 (da) 1985-11-07
DK514285A true DK514285A (da) 1986-05-14
DK159847B DK159847B (da) 1990-12-17
DK159847C DK159847C (da) 1991-05-13

Family

ID=24689433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK514285A DK159847C (da) 1984-11-13 1985-11-07 Salte af 5-cyanopyridin-2-diazohydroxid

Country Status (10)

Country Link
US (1) US4636564A (da)
EP (1) EP0181636B1 (da)
JP (1) JPS61158967A (da)
AT (1) ATE50566T1 (da)
AU (1) AU576914B2 (da)
CA (1) CA1255654A (da)
DE (1) DE3576154D1 (da)
DK (1) DK159847C (da)
ES (1) ES8700238A1 (da)
ZA (1) ZA858315B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816468A (en) * 1984-11-13 1989-03-28 The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and use
DE4301109A1 (de) * 1993-01-18 1994-07-21 Bayer Ag Verfahren zur Herstellung von 6-Amino-nicotinsäurenitrilen
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
CN107602456B (zh) * 2017-10-19 2021-04-06 北京印刷学院 偶氮吡啶盐化合物及制备方法

Also Published As

Publication number Publication date
ES8700238A1 (es) 1986-10-01
JPH0146511B2 (da) 1989-10-09
EP0181636A3 (en) 1987-04-01
DK159847B (da) 1990-12-17
DK159847C (da) 1991-05-13
DK514285D0 (da) 1985-11-07
ZA858315B (en) 1986-10-29
AU4983585A (en) 1986-05-22
ES548791A0 (es) 1986-10-01
ATE50566T1 (de) 1990-03-15
CA1255654A (en) 1989-06-13
AU576914B2 (en) 1988-09-08
DE3576154D1 (de) 1990-04-05
EP0181636B1 (en) 1990-02-28
US4636564A (en) 1987-01-13
EP0181636A2 (en) 1986-05-21
JPS61158967A (ja) 1986-07-18

Similar Documents

Publication Publication Date Title
GEP20002145B (en) Stem Cell Factor
BG60698B2 (en) Pharmaceutical ACCEPTABLE SALTS
DK99584A (da) Salte af omeprazol, fremgangsmaade til fremstilling deraf og anvendelse deraf
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
MY106280A (en) Novel benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use.
HUT49601A (en) Process for producing piperazine derivatives and salts thereof, as well as pharmaceutical compositions comprising such piperazine deriatives and salts thereof
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
EP0460062A4 (en) Method for the synthesis of huperzine a and analogs thereof and compounds useful therein
IT8548267A0 (it) Derivati di i,4-diidropiridina e suoi sali, procedimento per produrli e composizione farmaceutica cheli contiene
SE8405588D0 (sv) New compounds
DK514285D0 (da) 5-cyanopyridin-2-diazohydroxid, basiske salte og fremgangsmaader til deres fremstilling og anvendelse
BG105204A (en) Salts of paroxetine
NO932722L (no) Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
NO840526L (no) Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
DK524185A (da) Pyrazindiazohydroxidforbindelser og fremgangsmaader til deres fremstilling og anvendelse
IL77051A (en) Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
IL91152A0 (en) Furylthiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
ES8601200A1 (es) Un procedimiento para preparar compuestos de 3-(2-haloetil)-4-oxopirazolo-(5, 1-d)-1, 2, 3, 5-tetrazin-8-carboxamida
SE8405118D0 (sv) 4-kloro-furo-(3,4-c)-pyridin-derivat forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
ES8708226A1 (es) Procedimiento para la produccion de derivados de 1,4-dihi- dropiridina

Legal Events

Date Code Title Description
PBP Patent lapsed